ABarginase, the first-in-class drug for multiple obesity-related metabolic diseases
by Hong Kong Polytechnic University3D molecular models of ABarginase, albumin and FcRn receptor on a cell surface. Credit: Hong Kong Polytechnic UniversityResearchers from The Hong Kong Polytechn
Updated on: February 05,2024
21
ABarginase, the first-in-class drug for multiple obesity-related metabolic diseases
by Hong Kong Polytechnic University3D molecular models of ABarginase, albumin and FcRn receptor on a cell surface. Credit: Hong Kong Polytechnic UniversityResearchers from The Hong Kong Polytechn
Updated on:February 05,2024
21